Sol-gel coatings with lime repellent properties

Erworben im Rahmen der Schweizer Nationallizenzen (http://www.nationallizenzen.ch)Calcification of surfaces by hard water represents a major issue for sanitary installations. Calcium carbonate precipitates forming crusts of lime that are difficult to remove. Much effort has been undertaken to avoid scaling, most methods require chemicals or create waste. We constructed a test rig which allows for the controlled calcification of various substrates. It is found that all solid surfaces investigated calcify more or less evenly. On the other hand, surface bound poly(ethylene glycol), PEG, is known to prevent the non-specific adsorption of biomolecules. PEG coated surfaces find their use in a variety of applications. Here we show that glass and plastics, such as polyethylene, polypropylene and acrylonitrile-butadiene-styrene, can be efficiently made lime repellent by the use of sol-gel coatings containing a PEG bearing silane. It is shown that the amount of scaling is drastically reduced. Prior to coating, plastics have to be pretreated by oxygen plasma and an adhesion promoter has to be employed

Sol-gel coatings with lime repellent properties

Calcification of surfaces by hard water represents a major issue for sanitary installations. Calcium carbonate precipitates forming crusts of lime that are difficult to remove. Much effort has been undertaken to avoid scaling, most methods require chemicals or create waste. We constructed a test rig which allows for the controlled calcification of various substrates. It is found that all solid surfaces investigated calcify more or less evenly. On the other hand, surface bound poly(ethylene glycol), PEG, is known to prevent the non-specific adsorption of biomolecules. PEG coated surfaces find their use in a variety of applications. Here we show that glass and plastics, such as polyethylene, polypropylene and acrylonitrile-butadiene-styrene, can be efficiently made lime repellent by the use of sol-gel coatings containing a PEG bearing silane. It is shown that the amount of scaling is drastically reduced. Prior to coating, plastics have to be pretreated by oxygen plasma and an adhesion promoter has to be employe

Utilisation of copolymérisats en bloc dans polymérs pour prévention ou réduction d'adhésion de chaux

patent submitter:Geberit International AGDie vorliegende Erfindung betrifft die Verwendung eines Kunstoffs zur Verhinderung oder Verminderung von Ablagerungen, die Kalk enthalten oder daraus bestehen, sowie ein Verfahren zur Herstellung des Kunstoffs. Es werden haftungsverminderte Kunststoffe beschrieben, welche ein Matrixpolymer und ein Additiv aus Block-Copolymeren mit einem haftungsvermindernden oder haftungsverhindernden Teil und einem Ankerteilumfassen, wobei der haftungsvermindernde Teil oberflächenmodifizierende Polymere mit einem Heteroatomanteil von kleiner oder gleich 4 aufweist. Derart behandelte Oberflächen eignen sich zur Verhinderung oder zur Verminderung der Haftung von Ablagerungen, insbesondere auch von kalkhaltigen Ablagerungen

Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population.

Background.  Although acquired immune deficiency syndrome-associated morbidity has diminished due to excellent viral control, multimorbidity may be increasing among human immunodeficiency virus (HIV)-infected persons compared with the general population. Methods.  We assessed the prevalence of comorbidities and multimorbidity in participants of the Swiss HIV Cohort Study (SHCS) compared with the population-based CoLaus study and the primary care-based FIRE (Family Medicine ICPC-Research using Electronic Medical Records) records. The incidence of the respective endpoints were assessed among SHCS and CoLaus participants. Poisson regression models were adjusted for age, sex, body mass index, and smoking. Results.  Overall, 74 291 participants contributed data to prevalence analyses (3230 HIV-infected; 71 061 controls). In CoLaus, FIRE, and SHCS, multimorbidity was present among 26%, 13%, and 27% of participants. Compared with nonsmoking individuals from CoLaus, the incidence of cardiovascular disease was elevated among smoking individuals but independent of HIV status (HIV-negative smoking: incidence rate ratio [IRR] = 1.7, 95% confidence interval [CI] = 1.2-2.5; HIV-positive smoking: IRR = 1.7, 95% CI = 1.1-2.6; HIV-positive nonsmoking: IRR = 0.79, 95% CI = 0.44-1.4). Compared with nonsmoking HIV-negative persons, multivariable Poisson regression identified associations of HIV infection with hypertension (nonsmoking: IRR = 1.9, 95% CI = 1.5-2.4; smoking: IRR = 2.0, 95% CI = 1.6-2.4), kidney (nonsmoking: IRR = 2.7, 95% CI = 1.9-3.8; smoking: IRR = 2.6, 95% CI = 1.9-3.6), and liver disease (nonsmoking: IRR = 1.8, 95% CI = 1.4-2.4; smoking: IRR = 1.7, 95% CI = 1.4-2.2). No evidence was found for an association of HIV-infection or smoking with diabetes mellitus. Conclusions.  Multimorbidity is more prevalent and incident in HIV-positive compared with HIV-negative individuals. Smoking, but not HIV status, has a strong impact on cardiovascular risk and multimorbidity